EverPoint Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

EverPoint Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-71,000	Closed	-$5.24M	–	648
2015 Q4	$8.02M	Sell	71,000 -44,500	-39%	-$4.9M	0.17%	167
2015 Q3	$13.6M	Buy	+115,500	New	+$15.1M	0.35%	76
2015 Q1	–	Sell	-100,000	Closed	-$3.23M	–	680
2014 Q4	$3.23M	Buy	100,000 +50,000	+100%	+$1.5M	0.07%	307
2014 Q3	$1.22M	Buy	+50,000	New	+$1.02M	0.03%	381

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

EverPoint Asset Management's ANAC Position: Q1 2016 in Review

EverPoint Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 71,000 shares — an estimated $5.24M sold.

EverPoint Asset Management first reported a position in ANAC in Q3 2014 and held it in 4 quarters. The position peaked at $13.6M in Q3 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

EverPoint Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
EverPoint Asset Management sold 71,000 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $5.24M.
EverPoint Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 4 quarters.
EverPoint Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $13.6M in Q3 2015.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.